Drug Trial Radar · NCT07790861
A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems
Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
192
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Mar 2028
Study completion Mar 2028
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Aug 27, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to learn how well orforglipron works and how safe it is in Chinese adults with obesity or overweight and related health problems. Participation in this study will last about 53 weeks (about 1 year).
Conditions
- Obesity
- Overweight
Interventions
OrforglipronDrug
Administered orally.
PlaceboDrug
Administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Percent Change From Baseline in Body WeightTime frame: Baseline, Week 48
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Sichuan Provincial People's Hospital
Chengdu, China
Zhujiang Hospital
Guangzhou, China
The first Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
Zhejiang Provincial People's Hospital
Hangzhou, China
The Fourth Affiliated Hospital of Harbin Medical University
Harbin, China
The Second People's Hospital of Hefei
Hefei, China
Jinan Central Hospital
Jinan, China
The First Affiliated Hospital of Henan University of Science &Technology
Luoyang Shi, China
Jiangxi Provincial People's Hospital
Nanchang, China
Nanjing First Hospital
Nanjing, China
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, China
Jiangsu Province Hospital
Nanjing, China
Shanghai Sixth People's Hospital
Shanghai, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.